125 related articles for article (PubMed ID: 27468523)
1. Clinical Profile of Attention Deficit Hyperactivity Disorder: Impact of Ethnic and Social Diversities in Israel.
Mahaj M; Sharkia R; Shorbaji N; Zelnik N
Isr Med Assoc J; 2016 Jun; 18(6):322-5. PubMed ID: 27468523
[TBL] [Abstract][Full Text] [Related]
2. The Israel Survey of Mental Health among Adolescents: prevalence of attention-deficit/hyperactivity disorder, comorbidity, methylphenidate use, and help-seeking patterns.
Farbstein I; Mansbach-Kleinfeld I; Auerbach JG; Ponizovsky AM; Apter A
Isr Med Assoc J; 2014 Sep; 16(9):568-73. PubMed ID: 25351015
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
4. When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populations.
Manor I; Rozen S; Zemishlani Z; Weizman A; Zalsman G
Clin Neuropharmacol; 2011; 34(4):148-54. PubMed ID: 21738027
[TBL] [Abstract][Full Text] [Related]
5. Stimulant use for ADHD and relative age in class among children in Israel.
Hoshen MB; Benis A; Keyes KM; Zoëga H
Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):652-60. PubMed ID: 26823045
[TBL] [Abstract][Full Text] [Related]
6. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
7. The beneficial effect of methylphenidate in ADHD with comorbid separation anxiety.
Golubchik P; Golubchik L; Sever JM; Weizman A
Int Clin Psychopharmacol; 2014 Sep; 29(5):274-8. PubMed ID: 24743562
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of ADHD among 7-9-Year-Old Children in Israel. A Comparison between Jewish and Arab Populations.
Ornoy A; Ovadia M; Rivkin D; Milshtein E; Barlev L
Isr J Psychiatry Relat Sci; 2016; 53(2):3-8. PubMed ID: 28079031
[TBL] [Abstract][Full Text] [Related]
9. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel--a controversial issue.
Fogelman Y; Kahan E
Isr Med Assoc J; 2001 Dec; 3(12):925-7. PubMed ID: 11794916
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
Pliszka SR
J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
[TBL] [Abstract][Full Text] [Related]
11. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
12. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, diagnosis and treatment of ADHD in Arab and Jewish children in Israel, where are the gaps?
Shehadeh-Sheeny A; Baron-Epel O
BMC Psychiatry; 2023 Aug; 23(1):586. PubMed ID: 37568131
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of autism spectrum disorder in Israel: impact of ethnic and social diversities.
Mahajnah M; Sharkia R; Shalabe H; Terkel-Dawer R; Akawi A; Zelnik N
Biomed Res Int; 2015; 2015():962093. PubMed ID: 25984535
[TBL] [Abstract][Full Text] [Related]
15. Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder.
Gruber R
Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):863-76. PubMed ID: 19836693
[TBL] [Abstract][Full Text] [Related]
16. Is adult attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ?
Antshel KM; Faraone SV; Maglione K; Doyle A; Fried R; Seidman L; Biederman J
Psychol Med; 2009 Aug; 39(8):1325-35. PubMed ID: 19105857
[TBL] [Abstract][Full Text] [Related]
17. Attention deficit hyperactivity disorder: comorbidity and medication use.
Kube DA; Petersen MC; Palmer FB
Clin Pediatr (Phila); 2002 Sep; 41(7):461-9. PubMed ID: 12365307
[TBL] [Abstract][Full Text] [Related]
18. Two-year outcome of treatment with central stimulant medication in adult attention-deficit/hyperactivity disorder: a prospective study.
Bejerot S; Rydén EM; Arlinde CM
J Clin Psychiatry; 2010 Dec; 71(12):1590-7. PubMed ID: 20584517
[TBL] [Abstract][Full Text] [Related]
19. Attention deficit/hyperactivity disorder across the lifespan.
Wilens TE; Biederman J; Spencer TJ
Annu Rev Med; 2002; 53():113-31. PubMed ID: 11818466
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and psychiatric comorbidity of attention-deficit/hyperactivity disorder in an adolescent Finnish population.
Smalley SL; McGough JJ; Moilanen IK; Loo SK; Taanila A; Ebeling H; Hurtig T; Kaakinen M; Humphrey LA; McCracken JT; Varilo T; Yang MH; Nelson SF; Peltonen L; Järvelin MR
J Am Acad Child Adolesc Psychiatry; 2007 Dec; 46(12):1575-83. PubMed ID: 18030079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
